Prostate Cancer Clinical Trial
Official title:
A Cross-Sectional Study of the Predictability of a Questionnaire About Difficulty in Climbing Up or Down Stairs in Objective Measures of Functional Status in Elderly Patients With Prostate Cancer
The goal of this research study is to learn if your answers to questions during an interview
can help researchers predict how well you function physically and if you are at a high risk
for falls.
Primary Objectives:
-To determine how accurately a simple questionnaire can predict three objective measures of
function in elderly patients with prostate cancer.
Secondary Objectives:
- To assess the correlations between three functional tests and the number of
self-reported falls in elderly patients with prostate cancer.
- To determine risk factors related to number of falls in elderly prostate cancer
patients.
Physical Function Interview:
If you agree to take part in this study, you will be asked 6 questions. The first 2
questions ask about your physical ability to walk up and down stairs. The next 4 questions
ask about your history of falling down in the last year, symptoms of depression, loss of
urinary control, vision problems, and your ability to function physically. If you report
that you have fallen down more than 3 times in the last year, you will automatically be
referred for a physical therapy evaluation at M. D. Anderson.
Physical Function Tests:
After you have completed the questionnaires, you will perform 3 physical function tests:
- For the first test, you will sit in a chair, stand up, walk 10 feet as quickly and
safely as possible, turn around, return to the chair and sit again. This test will be
timed. You will perform this test 3 times, the average of the times will be recorded.
There will be no rest break between each test.
- For the next test, you will stand only on 1 leg as long as possible, and this time will
be recorded.
- You will complete a grip strength test. You will grip a small device in 1 hand and
squeeze as hard as you can while you are in a seated position. You will perform this
test 3 times and your best measurement will be recorded. There will be no rest period
between the 3 tests.
Symptom Assessment Interview:
After you complete the physical function tests, you will be asked to rate any symptoms you
experience on a scale from 0-10 (with 0 being the best and 10 being worst). You will be
asked to rate symptoms of things such as pain, fatigue, nausea, depression, anxiety,
drowsiness, and shortness of breath.
Medical Record Information:
Information will be collected from your medical record. This information will include your
age, race, gender, weight, height, body mass index, disease diagnosis, history of
chemotherapy and medications, and medical history.
Additional Information:
The physical function interview, tests of physical function, and symptom assessment
interview will take about 45 minutes total to complete during an already-scheduled visit to
the clinic.
Length of Study:
Your participation on this study will be over after you have completed the questionnaires,
physical function tests, and the symptom assessment.
This is an investigational study. Up to 60 people will take part in this study. All will be
enrolled at M. D. Anderson.
;
Observational Model: Cohort, Time Perspective: Prospective
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05613023 -
A Trial of 5 Fraction Prostate SBRT Versus 5 Fraction Prostate and Pelvic Nodal SBRT
|
Phase 3 | |
| Recruiting |
NCT05540392 -
An Acupuncture Study for Prostate Cancer Survivors With Urinary Issues
|
Phase 1/Phase 2 | |
| Recruiting |
NCT05156424 -
A Comparison of Aerobic and Resistance Exercise to Counteract Treatment Side Effects in Men With Prostate Cancer
|
Phase 1/Phase 2 | |
| Completed |
NCT03177759 -
Living With Prostate Cancer (LPC)
|
||
| Completed |
NCT01331083 -
A Phase II Study of PX-866 in Patients With Recurrent or Metastatic Castration Resistant Prostate Cancer
|
Phase 2 | |
| Recruiting |
NCT05540782 -
A Study of Cognitive Health in Survivors of Prostate Cancer
|
||
| Active, not recruiting |
NCT04742361 -
Efficacy of [18F]PSMA-1007 PET/CT in Patients With Biochemial Recurrent Prostate Cancer
|
Phase 3 | |
| Completed |
NCT04400656 -
PROState Pathway Embedded Comparative Trial
|
||
| Completed |
NCT02282644 -
Individual Phenotype Analysis in Patients With Castration-Resistant Prostate Cancer With CellSearch® and Flow Cytometry
|
N/A | |
| Recruiting |
NCT06305832 -
Salvage Radiotherapy Combined With Androgen Deprivation Therapy (ADT) With or Without Rezvilutamide in the Treatment of Biochemical Recurrence After Radical Prostatectomy for Prostate Cancer
|
Phase 2 | |
| Recruiting |
NCT06037954 -
A Study of Mental Health Care in People With Cancer
|
N/A | |
| Recruiting |
NCT05761093 -
Patient and Physician Benefit/ Risk Preferences for Treatment of mPC in Hong Kong: a Discrete Choice Experiment
|
||
| Completed |
NCT04838626 -
Study of Diagnostic Performance of [18F]CTT1057 for PSMA-positive Tumors Detection
|
Phase 2/Phase 3 | |
| Recruiting |
NCT03101176 -
Multiparametric Ultrasound Imaging in Prostate Cancer
|
N/A | |
| Completed |
NCT03290417 -
Correlative Analysis of the Genomics of Vitamin D and Omega-3 Fatty Acid Intake in Prostate Cancer
|
N/A | |
| Completed |
NCT00341939 -
Retrospective Analysis of a Drug-Metabolizing Genotype in Cancer Patients and Correlation With Pharmacokinetic and Pharmacodynamics Data
|
||
| Completed |
NCT01497925 -
Ph 1 Trial of ADI-PEG 20 Plus Docetaxel in Solid Tumors With Emphasis on Prostate Cancer and Non-Small Cell Lung Cancer
|
Phase 1 | |
| Recruiting |
NCT03679819 -
Single-center Trial for the Validation of High-resolution Transrectal Ultrasound (Exact Imaging Scanner ExactVu) for the Detection of Prostate Cancer
|
||
| Completed |
NCT03554317 -
COMbination of Bipolar Androgen Therapy and Nivolumab
|
Phase 2 | |
| Completed |
NCT03271502 -
Effect of Anesthesia on Optic Nerve Sheath Diameter in Patients Undergoing Robot-assisted Laparoscopic Prostatectomy
|
N/A |